01Identify the material that triggers the assay

Endotoxin is associated with the outer membrane of Gram-negative bacteria. FDA’s technical explanation distinguishes the endotoxin target from the wider group of substances capable of causing a pyrogenic response.FDA — Bacterial endotoxins and pyrogens (opens in a new tab)

A culture test requires detectable growth under its conditions. An endotoxin assay instead responds to the relevant bacterial material. The two measurements can therefore differ without being logically contradictory.

An endotoxin result does not name the bacterial species that originally contributed the material. Determining the origin of contamination requires evidence beyond the response of this assay.

02Read endotoxin units as calibrated activity

Endotoxin results commonly use EU, or endotoxin units. FDA’s March 2026 guidance explains the use of control standards calibrated to international reference endotoxin standards under defined assay conditions.FDA — Pyrogen and endotoxins testing, Edition 2 (opens in a new tab)

The number is consequently tied to a reference activity and method. It should not be treated as a universal conversion between nanograms of any bacterial lipopolysaccharide and endotoxin units.

Abate and colleagues compared structurally different lipopolysaccharides using recombinant factor C, LAL-based assays and a cell-based response. Some preparations showed different reactivity across the assays. Their experimental comparison illustrates why molecular source and assay response cannot be collapsed into a single universal mass factor.Abate and colleagues — Responses to different lipopolysaccharide structures (opens in a new tab)

A printed “EU” without enough sample context can refer to a total amount, a standard potency or an incompletely labelled concentration. Resolve that ambiguity before assessing the value.

03Follow the tested preparation back to the original sample

For an original illustrative result, suppose a suitable assay finds 0.020 EU/mL in a preparation that represents a 20-fold dilution of a liquid sample. The original-sample result is 0.400 EU/mL, provided the laboratory has not already made that correction.

If the preparation instead represents a powder extract, converting to EU/mg also requires the original material mass and represented extraction volume. The liquid measured by the instrument is not automatically the same reporting basis as the material supplied.

An assay limit must be converted in the same way. “Below 0.020 EU/mL” in the diluted preparation would correspond to a different bound in the original sample. A low displayed value cannot compensate for an inadequately sensitive final material limit.

These conversions describe analytical reporting only. They do not calculate a human dose, establish a product acceptance limit or make an unapproved research material suitable for administration.

04Use separate evidence for separate conclusions

FDA’s current guidance treats non-endotoxin pyrogens as a separate concern. A negative bacterial-endotoxin test should therefore not be expanded into an unrestricted “pyrogen-free” claim.FDA — Pyrogen and endotoxins testing, Edition 2 (opens in a new tab)

Likewise, an expected peptide identity or high chromatographic purity does not establish low endotoxin. A molecular assay and an endotoxin assay measure different features, even when both appear on one certificate.

The meaningful conclusion states the detected activity or reporting bound under a suitable method. If the test was inhibited or its sample basis is missing, address that limitation before drawing a reassuring conclusion from the number.